 | • レポートコード：MRC23Q36005 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、83ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のフローサイトメトリー抗体製品市場について調査・分析し、世界のフローサイトメトリー抗体製品市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（フローサイトメトリー用抗体、フローサイトメトリー用試薬、その他）、用途別セグメント分析（科学研究、製薬、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、Merck、BioLegend、Sino Biological Inc、Abcamなどが含まれています。世界のフローサイトメトリー抗体製品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、フローサイトメトリー抗体製品市場規模を推定する際に考慮しました。本レポートは、フローサイトメトリー抗体製品の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、フローサイトメトリー抗体製品に関するビジネス上の意思決定に役立てることを目的としています。 ・フローサイトメトリー抗体製品市場の概要 - フローサイトメトリー抗体製品のタイプ別セグメント - 世界のフローサイトメトリー抗体製品市場規模：タイプ別分析（フローサイトメトリー用抗体、フローサイトメトリー用試薬、その他） - フローサイトメトリー抗体製品の用途別セグメント - 世界のフローサイトメトリー抗体製品市場規模：用途別分析（科学研究、製薬、その他） - 世界のフローサイトメトリー抗体製品市場規模予測（2018年-2029年） ・フローサイトメトリー抗体製品市場の成長トレンド - フローサイトメトリー抗体製品の地域別市場規模（2018年-2029年） - フローサイトメトリー抗体製品市場ダイナミクス - フローサイトメトリー抗体製品の業界動向 - フローサイトメトリー抗体製品市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：フローサイトメトリー用抗体、フローサイトメトリー用試薬、その他 - 世界のフローサイトメトリー抗体製品のタイプ別市場規模（2018年-2023年） - 世界のフローサイトメトリー抗体製品のタイプ別市場規模（2024年-2029年） ・用途別セグメント：科学研究、製薬、その他 - 世界のフローサイトメトリー抗体製品の用途別市場規模（2018年-2023年） - 世界のフローサイトメトリー抗体製品の用途別市場規模（2024年-2029年） ・フローサイトメトリー抗体製品の地域別市場規模 - 北米のフローサイトメトリー抗体製品市場規模（2018年-2029年） - アメリカのフローサイトメトリー抗体製品市場規模（2018年-2029年） - ヨーロッパのフローサイトメトリー抗体製品市場規模（2018年-2029年） - アジア太平洋のフローサイトメトリー抗体製品市場規模（2018年-2029年） - 中国のフローサイトメトリー抗体製品市場規模（2018年-2029年） - 日本のフローサイトメトリー抗体製品市場規模（2018年-2029年） - 韓国のフローサイトメトリー抗体製品市場規模（2018年-2029年） - インドのフローサイトメトリー抗体製品市場規模（2018年-2029年） - オーストラリアのフローサイトメトリー抗体製品市場規模（2018年-2029年） - 中南米のフローサイトメトリー抗体製品市場規模（2018年-2029年） - 中東・アフリカのフローサイトメトリー抗体製品市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、Merck、BioLegend、Sino Biological Inc、Abcam ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Flow Cytometry Antibody Products market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Flow Cytometry Antibody Products is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Flow Cytometry Antibody Products is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Flow Cytometry Antibody Products in Scientific Research is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Flow Cytometry Antibody Products include Thermo Fisher Scientific, Merck, BioLegend, Sino Biological Inc and Abcam, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flow Cytometry Antibody Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flow Cytometry Antibody Products.
The Flow Cytometry Antibody Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Flow Cytometry Antibody Products market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flow Cytometry Antibody Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Merck
BioLegend
Sino Biological Inc
Abcam
Segment by Type
Flow Cytometry Antibodies
Flow Cytometry Reagents
Other
Segment by Application
Scientific Research
Pharmaceutical Manufacturing
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flow Cytometry Antibody Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Flow Cytometry Antibody Products Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Flow Cytometry Antibodies
1.2.3 Flow Cytometry Reagents
1.2.4 Other
1.3 Market by Application
1.3.1 Global Flow Cytometry Antibody Products Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Scientific Research
1.3.3 Pharmaceutical Manufacturing
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Flow Cytometry Antibody Products Market Perspective (2018-2029)
2.2 Flow Cytometry Antibody Products Growth Trends by Region
2.2.1 Global Flow Cytometry Antibody Products Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Flow Cytometry Antibody Products Historic Market Size by Region (2018-2023)
2.2.3 Flow Cytometry Antibody Products Forecasted Market Size by Region (2024-2029)
2.3 Flow Cytometry Antibody Products Market Dynamics
2.3.1 Flow Cytometry Antibody Products Industry Trends
2.3.2 Flow Cytometry Antibody Products Market Drivers
2.3.3 Flow Cytometry Antibody Products Market Challenges
2.3.4 Flow Cytometry Antibody Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Flow Cytometry Antibody Products Players by Revenue
3.1.1 Global Top Flow Cytometry Antibody Products Players by Revenue (2018-2023)
3.1.2 Global Flow Cytometry Antibody Products Revenue Market Share by Players (2018-2023)
3.2 Global Flow Cytometry Antibody Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Flow Cytometry Antibody Products Revenue
3.4 Global Flow Cytometry Antibody Products Market Concentration Ratio
3.4.1 Global Flow Cytometry Antibody Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Flow Cytometry Antibody Products Revenue in 2022
3.5 Flow Cytometry Antibody Products Key Players Head office and Area Served
3.6 Key Players Flow Cytometry Antibody Products Product Solution and Service
3.7 Date of Enter into Flow Cytometry Antibody Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Flow Cytometry Antibody Products Breakdown Data by Type
4.1 Global Flow Cytometry Antibody Products Historic Market Size by Type (2018-2023)
4.2 Global Flow Cytometry Antibody Products Forecasted Market Size by Type (2024-2029)
5 Flow Cytometry Antibody Products Breakdown Data by Application
5.1 Global Flow Cytometry Antibody Products Historic Market Size by Application (2018-2023)
5.2 Global Flow Cytometry Antibody Products Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Flow Cytometry Antibody Products Market Size (2018-2029)
6.2 North America Flow Cytometry Antibody Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Flow Cytometry Antibody Products Market Size by Country (2018-2023)
6.4 North America Flow Cytometry Antibody Products Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Flow Cytometry Antibody Products Market Size (2018-2029)
7.2 Europe Flow Cytometry Antibody Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Flow Cytometry Antibody Products Market Size by Country (2018-2023)
7.4 Europe Flow Cytometry Antibody Products Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Flow Cytometry Antibody Products Market Size (2018-2029)
8.2 Asia-Pacific Flow Cytometry Antibody Products Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Flow Cytometry Antibody Products Market Size by Region (2018-2023)
8.4 Asia-Pacific Flow Cytometry Antibody Products Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Flow Cytometry Antibody Products Market Size (2018-2029)
9.2 Latin America Flow Cytometry Antibody Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Flow Cytometry Antibody Products Market Size by Country (2018-2023)
9.4 Latin America Flow Cytometry Antibody Products Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Flow Cytometry Antibody Products Market Size (2018-2029)
10.2 Middle East & Africa Flow Cytometry Antibody Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Flow Cytometry Antibody Products Market Size by Country (2018-2023)
10.4 Middle East & Africa Flow Cytometry Antibody Products Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Flow Cytometry Antibody Products Introduction
11.1.4 Thermo Fisher Scientific Revenue in Flow Cytometry Antibody Products Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Flow Cytometry Antibody Products Introduction
11.2.4 Merck Revenue in Flow Cytometry Antibody Products Business (2018-2023)
11.2.5 Merck Recent Development
11.3 BioLegend
11.3.1 BioLegend Company Detail
11.3.2 BioLegend Business Overview
11.3.3 BioLegend Flow Cytometry Antibody Products Introduction
11.3.4 BioLegend Revenue in Flow Cytometry Antibody Products Business (2018-2023)
11.3.5 BioLegend Recent Development
11.4 Sino Biological Inc
11.4.1 Sino Biological Inc Company Detail
11.4.2 Sino Biological Inc Business Overview
11.4.3 Sino Biological Inc Flow Cytometry Antibody Products Introduction
11.4.4 Sino Biological Inc Revenue in Flow Cytometry Antibody Products Business (2018-2023)
11.4.5 Sino Biological Inc Recent Development
11.5 Abcam
11.5.1 Abcam Company Detail
11.5.2 Abcam Business Overview
11.5.3 Abcam Flow Cytometry Antibody Products Introduction
11.5.4 Abcam Revenue in Flow Cytometry Antibody Products Business (2018-2023)
11.5.5 Abcam Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details